PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 30, 2025Scientific Reports1 citationsOpen Access

Explainable artificial intelligence identifies and localizes left ventricular scar in hypertrophic cardiomyopathy using 12-Lead electrocardiogram

View Full Paper
KNKasra NezamabadiSSSanjay SivalokanathanJLJiwon Lee

Structured PICO

Does an explainable machine learning model using 12-lead ECG data accurately identify left ventricular scar in patients with hypertrophic cardiomyopathy?

P
Population
748 patients with hypertrophic cardiomyopathy (HCM) from two centers (500 from Johns Hopkins hospital, 248 from UCSF)
I
Intervention
XplainScar (an explainable machine learning model analyzing 12-lead ECG data)
C
Comparator
Late gadolinium enhancement MRI (reference standard for LV scar detection)
O
Outcome
Prediction of left ventricular (LV) scar presencesurrogate

An explainable machine learning model using standard 12-lead ECGs can accurately detect left ventricular scar in patients with hypertrophic cardiomyopathy, offering a potential cost-effective alternative to MRI.

Abstract

Left ventricular (LV) scar is a major risk factor for sudden death and heart failure in hypertrophic cardiomyopathy (HCM). LV scar evolves over time and needs longitudinal assessment. Currently, LV scar detection relies on late gadolinium enhancement MRI, which is limited by high cost and artifacts from implanted cardiac devices. To address this, we developed XplainScar, an explainable machine learning model that identifies LV scar using 12-lead electrocardiogram (ECG) data. XplainScar was trained and validated on retrospective data from 748 HCM patients across two centers (500 from Johns Hopkins hospital for model development, and 248 from UCSF for validation). XplainScar employs a combination of unsupervised and self-supervised representation learning to effectively predict scar presence, and discover ECG features associated with LV scar. XplainScar rapidly analyzes ECG data (< 1 min for 10 patients) and demonstrates strong predictive performance on the held-out test set, achieving an F1-score of 89%, sensitivity of 90%, specificity of 78%, and precision of 88%. By providing an effective, cost-effective, and transparent alternative to MRI, XplainScar has the potential to assist with patient care, and reduce healthcare costs related to LV scar monitoring in HCM. XplainScar is available at https://github.com/KasraNezamabadi/XplainScar .

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Nezamabadi et al. (2025) studied this question.

synapsesocial.com/papers/69f53f98b76c9a4576d8d079https://doi.org/10.1038/s41598-025-09282-7
Ask AI
Helpful
Bookmark
Share
View Full Paper